These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 7543218

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
    Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R, Clozapine and Risperidone Enhancement (CARE) Study Group.
    N Engl J Med; 2006 Feb 02; 354(5):472-82. PubMed ID: 16452559
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Schizophrenia: recent advances in psychopharmacology.
    Sharma T.
    Br J Hosp Med; 2006 Feb 02; 55(4):194-8. PubMed ID: 8777500
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal.
    Shiovitz TM, Welke TL, Tigel PD, Anand R, Hartman RD, Sramek JJ, Kurtz NM, Cutler NR.
    Schizophr Bull; 1996 Feb 02; 22(4):591-5. PubMed ID: 8938913
    [Abstract] [Full Text] [Related]

  • 48. Immediate recurrence of psychotic symptoms after discontinuation of clozapine: a case report.
    Tanríverdi N, Yazící KM.
    Biol Psychiatry; 1996 May 01; 39(9):814-5. PubMed ID: 8731523
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S, Katz G, Zislin Z, Knobler HY, Durst R.
    Acta Psychiatr Scand; 2000 Apr 01; 101(4):334-6. PubMed ID: 10782556
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Risperidone: clinical safety and efficacy in schizophrenia.
    Borison RL, Pathiraja AP, Diamond BI, Meibach RC.
    Psychopharmacol Bull; 1992 Apr 01; 28(2):213-8. PubMed ID: 1381102
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Addressing emerging social needs of patients treated with new neuroleptics.
    Clarke DE, Yaeger SF.
    J Psychosoc Nurs Ment Health Serv; 1994 Nov 01; 32(11):19-22. PubMed ID: 7533837
    [Abstract] [Full Text] [Related]

  • 56. Clinical considerations in the use of risperidone.
    Remington GJ.
    Can J Psychiatry; 1993 Sep 01; 38 Suppl 3():S96-100. PubMed ID: 7504575
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Supersensitivity psychosis in a case with clozapine tolerance.
    Ozcan S, Soydan A, Tamam L.
    Eur Rev Med Pharmacol Sci; 2012 Oct 01; 16 Suppl 4():70-3. PubMed ID: 23090814
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.